Zepbound sheds more weight than Wegovy in trial, Eli Lilly says - NBC News
3 days ago · People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a head-to-head clinical trial, Lilly said in a news release Wednesday.
Eli Lilly's Zepbound tops Wegovy in head-to-head weight loss trial
3 days ago · Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in the first large, head-to-head trial of the highly in ...
Zepbound tops Wegovy for weight loss in Eli Lilly study
3 days ago · Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% for Wegovy. The drugmaker also said more patients taking Zepbound achieved at least 25% weight loss. The study results should help fuel Zepbound’s accelerating market-share gains, Leerink Partners analyst David Risinger said in a research note.
Lilly's Zepbound Beats Wegovy in Weight-Loss Drug Trial
3 days ago · Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters. In the study sponsored by Lilly, those on ...
What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
Wegovy is a weight-loss drug. Health Canada says it can now be …
Nov 27, 2024 · Health Canada has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of non-fatal heart attack, the drug maker says. Novo Nordisk said Wednesday that Wegovy is the first Health ...
Results of Wegovy's longest clinical trial on weight loss ... - CTV News
May 14, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how...
Wegovy weight-loss drug reduced risk of serious heart ... - CBS News
Nov 13, 2023 · The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20%, according to a large, international study paid for by Novo Nordisk, the drugmaker behind the product.
Weight-loss drug Wegovy cuts risk of stroke, heart attacks ... - NBC News
Aug 8, 2023 · Weight loss from the drug could potentially provide benefits comparable to those of bariatric surgery, which has been shown to reduce the risk of death from cancer, diabetes, heart disease...
Weight Loss Drug Cuts Risk of Heart Problems, Maker Says - The …
Aug 8, 2023 · A new obesity drug, Wegovy, slashed the risk of serious heart problems by 20 percent in a large trial, the drug’s maker said on Tuesday, a finding that could challenge the perception of...
- Some results have been removed